Back to the main directory
Press Release
- Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission by GlobeNewsWire
- BrainsWay Vice President of Medical Affairs Colleen Hanlon Honored with the 2023 International Brain Stimulation Early Career Award by GlobeNewsWire
- BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma by GlobeNewsWire
- Ardelyx to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 2, 2023 by GlobeNewsWire
- LPGA, Pacira BioSciences Partner to Raise Awareness of Non-Opioid Pain Management Solutions by GlobeNewsWire
- Rain Oncology to Report Fourth Quarter and Full Year 2022 Financial Results and Highlights of Recent Progress on March 9, 2023 by GlobeNewsWire
- Golden Matrix Reports Record First Quarter Revenues Exceeding $10.5 Million by GlobeNewsWire
- Where Food Comes From, Inc. Reports 2022 Fourth Quarter and Full Year Financial Results by GlobeNewsWire
- Elys Game Technology Signs Agreement to Operate a Sportsbook at The Ugly Mug in Washington, DC by GlobeNewsWire
- Clinical Data Supports the Role of Ultrafiltration in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) by GlobeNewsWire
- BriaCell Reports Positive Survival Data in Advanced Metastatic Breast Cancer by GlobeNewsWire
- Registration Now Open For Tribe Public’s Webinar Event “Sustainable Products Solving EVs' Biggest Challenges” Featuring Beam Global’s CEO On February 28, 2023 by GlobeNewsWire
- Luckin Coffee to Announce Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023 by GlobeNewsWire
- ReWalk Robotics Reports Fourth Quarter and Full Year 2022 Financial Results by GlobeNewsWire
- Talkspace to Participate in Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference by GlobeNewsWire
- Teknova to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023 by GlobeNewsWire
- Microbot Medical’s Remote Controller for the LIBERTY® Robotic System Receives Design Patent Allowance in Japan by GlobeNewsWire
- Synchronoss presenta la plataforma Personal Cloud activada por IA en el Mobile World Congress by GlobeNewsWire
- Synchronoss Akan Memamerkan Platform Personal Cloud Berdaya AI di Mobile World Congress by GlobeNewsWire
- Synchronoss, Mobile World Congress에서 AI 구동 Personal Cloud 플랫폼 선보일 예정 by GlobeNewsWire
- Synchronoss Introduz Plataforma de Nuvem Pessoal Alimentada por IA no Mobile World Congress by GlobeNewsWire
- Synchronoss เตรียมจัดแสดงแพลตฟอร์ม Personal Cloud ที่ขับเคลื่อนด้วย AI ที่งาน Mobile World Congress by GlobeNewsWire
- EQS-News: TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders by EQS Group AG
- uniQure Announces HOPE-B Clinical Trial Data Published in the New England Journal of Medicine, Demonstrating Durability and Other Benefits of HEMGENIX® (etranacogene dezaparvovec-drlb) by GlobeNewsWire
- Le Fonds de revenu Noranda annonce l’augmentation du prix d’achat à 1,98 $ par part prioritaire et la conclusion de conventions de soutien avec des porteurs de parts représentant environ 22 % des parts prioritaires by GlobeNewsWire